Bolis G - Search Results

1

Vulvar lichen sclerosus: A new regenerative approach through fat grafting.

Boero V, Brambilla M, Sipio E, Liverani CA, Di Martino M, Agnoli B, Libutti G, Cribiù FM, Del Gobbo A, Ragni E, Bolis G. Boero V, et al. Among authors: bolis g. Gynecol Oncol. 2015 Dec;139(3):471-5. doi: 10.1016/j.ygyno.2015.10.014. Epub 2015 Oct 21. Gynecol Oncol. 2015. PMID: 26499935

2

Hypertrophic donavanosis in a young pregnant woman.

Liverani CA, Lattuada D, Mangano S, Pignatari C, Puglia D, Monti E, Bolis G. Liverani CA, et al. Among authors: bolis g. J Pediatr Adolesc Gynecol. 2012 Aug;25(4):e81-3. doi: 10.1016/j.jpag.2011.10.002. J Pediatr Adolesc Gynecol. 2012. PMID: 22840941

3

Length but not transverse diameter of the excision specimen for high-grade cervical intraepithelial neoplasia (CIN 2-3) is a predictor of pregnancy outcome.

Liverani CA, Di Giuseppe J, Clemente N, Delli Carpini G, Monti E, Fanetti F, Bolis G, Ciavattini A. Liverani CA, et al. Among authors: bolis g. Eur J Cancer Prev. 2016 Sep;25(5):416-22. doi: 10.1097/CEJ.0000000000000196. Eur J Cancer Prev. 2016. PMID: 26317385

4

Prevalence of unexpected leiomyosarcoma at myomectomy: a descriptive study.

Vercellini P, Cribiù FM, Bosari S, Scarfone G, Bolis G, Aimi G, Fedele L. Vercellini P, et al. Among authors: bolis g. Am J Obstet Gynecol. 2016 Feb;214(2):292-294. doi: 10.1016/j.ajog.2015.09.092. Epub 2015 Oct 9. Am J Obstet Gynecol. 2016. PMID: 26450408 No abstract available.

5

Survival and prognostic factors of women with advanced ovarian cancer and complete response after a carboplatin-paclitaxel chemotherapy.

Polverino G, Parazzini F, Stellato G, Scarfone G, Cipriani S, Bolis G. Polverino G, et al. Among authors: bolis g. Gynecol Oncol. 2005 Nov;99(2):343-7. doi: 10.1016/j.ygyno.2005.06.008. Epub 2005 Jul 26. Gynecol Oncol. 2005. PMID: 16051334 Clinical Trial.

6

EMA/CO regimen in high-risk gestational trophoblastic tumor (GTT).

Bolis G, Bonazzi C, Landoni F, Mangili G, Vergadoro F, Zanaboni F, Mangioni C. Bolis G, et al. Gynecol Oncol. 1988 Nov;31(3):439-44. doi: 10.1016/s0090-8258(88)80029-5. Gynecol Oncol. 1988. PMID: 2846414

7

Response and toxicity to topotecan in sensitive ovarian cancer cases with small residual disease after first-line treatment with carboplatinum and paclitaxel.

Bolis G, Scarfone G, Tateo S, Mangili G, Villa A, Parazzini F. Bolis G, et al. Gynecol Oncol. 2001 Jan;80(1):13-5. doi: 10.1006/gyno.2000.5995. Gynecol Oncol. 2001. PMID: 11136562 Clinical Trial.

8

A phase I/II study of topotecan in combination with carboplatin in recurrent epithelial ovarian cancer.

Bolis G, Scarfone G, Sciatta C, Polverino GP, Rosa C, Guarnerio P, Parazzini F. Bolis G, et al. Gynecol Oncol. 2001 Dec;83(3):477-80. doi: 10.1006/gyno.2001.6399. Gynecol Oncol. 2001. PMID: 11733958 Clinical Trial.

9

Salvage chemotherapy for ovarian cancer recurrence: weekly cisplatin in combination with epirubicin or etoposide.

Zanaboni F, Scarfone G, Presti M, Maggi R, Borello C, Bolis G. Zanaboni F, et al. Among authors: bolis g. Gynecol Oncol. 1991 Oct;43(1):24-8. doi: 10.1016/0090-8258(91)90004-o. Gynecol Oncol. 1991. PMID: 1959783 Clinical Trial.

10

The impact of whole-abdomen radiotherapy on survival in advanced ovarian cancer patients with minimal residual disease after chemotherapy.

Bolis G, Zanaboni F, Vanoli P, Russo A, Franchi M, Scarfone G, Pecorelli S. Bolis G, et al. Gynecol Oncol. 1990 Nov;39(2):150-4. doi: 10.1016/0090-8258(90)90423-i. Gynecol Oncol. 1990. PMID: 2227589

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results